Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
| 2014 | 70 | |||
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Research and Treatment | 2021 | 38 | ||
Patient–clinician relationship seems to affect adherence to analgesic use in cancer patients: a cross sectional study in a Taiwanese population Journal:International Journal for Quality in Health Care | 2017 | 47 |